Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plague.

R W Titball1, S E Leary

  • 1Defence Evaluation and Research Agency, CBD Porton Down, Salisbury, UK.

British Medical Bulletin
|May 18, 1999
PubMed
Summary
This summary is machine-generated.

Plague remains a public health concern, with Yersinia pestis causing thousands of cases yearly. New subunit vaccines show promise for preventing both bubonic and pneumonic plague.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of RelA and SpoT in Burkholderia pseudomallei survival, biofilm formation and ceftazidime tolerance during nutritional stress.

Tropical biomedicine·2021
Same author

Burkholderia thailandensis strain E555 is a surrogate for the investigation of Burkholderia pseudomallei replication and survival in macrophages.

BMC microbiology·2019
Same author

Novel multi-component vaccine approaches for Burkholderia pseudomallei.

Clinical and experimental immunology·2019
Same author

Clostridium perfringensα-toxin interaction with red cells and model membranes.

Soft matter·2015
Same author

Salmonella Gallinarum field isolates from laying hens are related to the vaccine strain SG9R.

Vaccine·2013
Same author

Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity.

Vaccine·2012
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
Same journal

Enhancing bone healing through osteogenic medium components: biological roles, mechanisms, and clinical applications.

British medical bulletin·2026
Same journal

Moral injury in healthcare workers: causes & interventions.

British medical bulletin·2026
See all related articles

Area of Science:

  • Microbiology
  • Epidemiology
  • Infectious Diseases

Background:

  • Yersinia pestis, the bacterium responsible for plague, has historically caused widespread social disruption.
  • Plague continues to be a significant public health issue, with over 2000 cases reported annually worldwide.
  • Pneumonic plague, a severe form of the disease, can spread rapidly between individuals, posing a pandemic threat.

Purpose of the Study:

  • To highlight the ongoing public health threat of plague.
  • To emphasize the need for effective vaccines and treatments against Yersinia pestis.
  • To report on advancements in plague vaccine development.

Main Methods:

  • Review of historical plague outbreaks and current epidemiological data.
  • Assessment of the potential for rapid global spread via modern transportation.

Related Experiment Videos

  • Evaluation of progress in developing a Yersinia pestis sub-unit vaccine.

    • Main Results:

    • Plague affects at least 2000 individuals each year, primarily in its bubonic form.
    • Pneumonic plague can emerge from bubonic plague and spread quickly, as demonstrated by recent outbreaks.
    • A promising sub-unit vaccine effective against both bubonic and pneumonic plague has been developed.

    Conclusions:

    • Despite advances, plague remains an active threat requiring ongoing surveillance and preparedness.
    • Early antibiotic administration is crucial for treating plague effectively.
    • The development of a sub-unit vaccine offers a new strategy for controlling plague outbreaks.